Galatea Bio designs and executes projects leveraging human genetic diversity for biomedical problem-solving. The company offers clinical testing services through a CLIA-CMS certified molecular diagnostics laboratory and biobank infrastructure. They partner with life sciences organizations to build large-scale population sequencing programs utilizing an extensive genomic-phenotypic data lake.
Funding
$25.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current precision health initiatives often lack comprehensive genetic testing and biobanking solutions, particularly for diverse populations, which limits the scope and applicability of biomedical research. Existing solutions may not adequately address participant privacy concerns, hindering participation and data availability.
Solution
Galatea Bio offers end-to-end genomic services and a large-scale genomic-phenotypic data lake designed to advance precision health for all populations. The company operates a CLIA-certified and CAP-accredited next-generation sequencing (NGS) molecular diagnostics clinical laboratory and biobank. Galatea Bio partners with pharmaceutical and life sciences organizations, academic universities, and health systems to build large-scale population sequencing programs. Their platform leverages a private genomic-phenotypic data lake and AI algorithms to solve problems in biomedicine while respecting research participant integrity, autonomy, and privacy.
Target Audience
Galatea Bio serves academic and private organizations, pharmaceutical and life sciences companies, academic universities, health systems, and physicians seeking comprehensive genetic testing and biobanking solutions.
Features
- Full-stack infrastructure with a next-generation sequencing (NGS) molecular diagnostics clinical laboratory
- CLIA-certified and CAP-accredited high-complexity lab
- Large-scale population sequencing program consortiums
- Proprietary genomic-phenotypic data lake
- AI and algorithms for advanced biomedical research
- Disease registries for epidemiological and genomics investigations
- Biospecimen storage partnerships